Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Daniel Meltzer

Optometrist Iselin, NJ Doctor of Optometry

NPI 1508927690 CMS profile 833086

675 Rt.1 And Gill Ln., Iselin, NJ 08830

Open in the dashboard

General payments

$1,985

57 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Daniel Meltzer of Iselin, NJ is reported in the CMS Open Payments database as having received $1,985 across 57 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $411 9
2024 General $427 15
2023 General $605 14
2022 General $27 2
2021 General $123 1
2020 General $76 4
2019 General $315 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Meltzer
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Daniel Meltzer were reported at $411. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Daniel Meltzer Optometrist median Middle half National median
2019 $315 $159 $67–$371 $163
2020 $76 $72 $29–$165 $114
2021 $123 $125 $46–$292 $132
2022 $27 $162 $66–$374 $149
2023 $605 $177 $72–$406 $160
2024 $427 $188 $77–$427 $164
2025 $411 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alcon Vision LLC $681 19 payments
  2. Bausch & Lomb Americas Inc. $547 17 payments
  3. CooperVision Inc. $247 12 payments
  4. Sight Sciences, Inc. $182 2 payments
  5. Visioneering Technologies, Inc. $168 2 payments
  6. Johnson & Johnson Surgical Vision, Inc. $105 2 payments
  7. Menicon $34 2 payments
  8. Johnson & Johnson Vision Care, Inc. $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,985 57 payments
Products named General payments · program years 2019–2025
  1. INFUSE $547 17 payments
  2. TOTAL30 $196 5 payments
  3. BIOTRUE $123 7 payments
  4. Clareon $108 1 payment
  5. Tecnis IOL Optics $105 2 payments
  6. Tecnis IOL Optics $105 2 payments
  7. CATALYS SYSTEM $105 2 payments
  8. ReSTOR $104 1 payment
  9. MyDay Contact Lens $103 5 payments
  10. Clariti Contact Lens $102 5 payments
  11. Other $471 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 5 billing codes

Paid by Medicare

$5,492

Medicare's payments for the services billed

Medicare patients

50

Average age 74

Services billed

70

29 women, 21 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 42%
Arthritis 34%
Diabetes 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

57 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record